Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Tubo-ovarian abscess

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Rupture and sepsis need immediate source control

Shock, confusion, rising lactate, rigid abdomen, diffuse peritonism or sudden deterioration in a patient with a pelvic abscess suggests sepsis, rupture or uncontrolled infection.

Action: Use ABCDE and the sepsis pathway, obtain cultures without delaying treatment, start protocol-led intravenous broad-spectrum antibiotics, call senior gynaecology, anaesthesia and microbiology, and arrange urgent drainage or surgery.

Synopsis

Recognise tubo-ovarian abscess as severe polymicrobial pelvic infection, start precise inpatient antimicrobial treatment, and escalate promptly to image-guided drainage or surgery when source control is needed.

  • A tubo-ovarian abscess is an inflammatory mass involving fallopian tube, ovary and adjacent tissues, most often representing severe ascending pelvic inflammatory disease with polymicrobial aerobic and anaerobic infection.
  • Symptoms include lower abdominal pain, fever, deep dyspareunia, abnormal discharge or bleeding; examination may show lower abdominal, cervical-motion and adnexal tenderness, but no feature is sufficiently sensitive to exclude disease.
  • Obtain pregnancy testing, STI nucleic-acid tests including gonorrhoea and chlamydia, HIV and syphilis testing, full blood count, CRP, renal and liver profiles, and cultures when septic; negative cervical tests do not exclude upper-tract infection.
  • Transvaginal ultrasound usually identifies a thick-walled complex adnexal collection, dilated tube, internal debris and hyperaemia; CT helps when bowel, appendix, urinary disease or wider abdominal sepsis is possible.
  • A tubo-ovarian abscess warrants hospital care, intravenous broad-spectrum treatment and early senior review; BASHH recommends parenteral therapy for severe disease and abscess.
  • One BASHH inpatient regimen is ceftriaxone 2 g IV daily plus doxycycline 100 mg twice daily, switching after improvement to oral doxycycline 100 mg twice daily plus metronidazole 400 mg twice daily to complete 14 days.
  • An alternative is clindamycin 900 mg IV three times daily plus gentamicin with level-guided dosing, followed by clindamycin or doxycycline with metronidazole to complete 14 days.
  • Drain percutaneously, transvaginally or surgically when rupture, sepsis, diagnostic uncertainty, persistent collection or inadequate clinical response makes antibiotics alone insufficient; ultrasound-guided aspiration is less invasive than laparoscopy in suitable anatomy.

Key red flags

Hypotension, altered mental state, mottling, oliguria, hypoxia or elevated lactate indicates organ dysfunction and requires immediate sepsis escalation.

Sudden generalised pain, guarding or rigid abdomen in a known abscess raises concern for rupture and emergency operative source control.

Pregnancy with pelvic pain or a mass requires specialist admission because ectopic pregnancy, obstetric infection and antimicrobial safety alter management.

Failure to improve clinically within 72 hours of appropriate treatment should trigger renewed imaging, microbiology review and drainage or surgery assessment.

Postmenopausal presentation, unusual organisms, recurrent abscess or a persistent mass after infection resolves warrants investigation for malignancy, bowel disease or another source.

Investigation priorities

01
Immediate pregnancy testFirst step

Exclude ectopic pregnancy and identify a context requiring obstetric and antimicrobial modification.

Management branches

Sepsis or ruptureResuscitate and obtain urgent source control

Organ dysfunction, shock, diffuse peritonism or sudden deterioration suggests uncontrolled or ruptured abscess.

  1. Use ABCDE, send blood cultures and lactate where indicated, start intravenous broad-spectrum antibiotics promptly and provide protocol-led fluid resuscitation.
  2. Call senior gynaecology, anaesthesia, microbiology and relevant surgical teams, arranging CT only if stable enough and it will change immediate source control.
  3. Proceed to urgent drainage, laparoscopy or laparotomy according to physiology and anatomy, obtaining pus cultures and controlling contamination.
Confirmed stable abscessAdmit for parenteral treatment

Imaging supports tubo-ovarian abscess without current rupture or organ dysfunction.

  1. Review allergy, pregnancy, renal and hepatic function, obtain microbiology samples and start a BASHH-supported inpatient antimicrobial regimen.
  2. Record collection dimensions and drainage accessibility, involve senior gynaecology early and provide analgesia, fluids and thrombosis assessment.
  3. Track clinical improvement closely and switch to oral completion therapy only after sustained response and a secure source-control plan.

Key medicines

Ceftriaxone, doxycycline and metronidazoleCeftriaxone 2 g intravenously once daily plus doxycycline 100 mg intravenously or orally twice daily; continue parenteral therapy until 24 hours after clinical improvement, then doxycycline 100 mg orally twice daily plus metronidazole 400 mg orally twice daily to complete 14 days total.Check immediate beta-lactam allergy, pregnancy, liver function and interacting medicines; doxycycline can cause oesophagitis and photosensitivity and is generally avoided in pregnancy, so obtain specialist obstetric and microbiology advice.
Clindamycin and gentamicin alternativeClindamycin 900 mg intravenously three times daily plus gentamicin 2 mg/kg loading then 1.5 mg/kg three times daily; after improvement use clindamycin 450 mg orally four times daily, or doxycycline 100 mg twice daily plus metronidazole 400 mg twice daily, to complete 14 days.Use actual protocol weight and monitor gentamicin concentrations and renal function because nephrotoxicity and ototoxicity are exposure related; review pregnancy, neuromuscular disease, diarrhoea and Clostridioides difficile risk.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BASHH UK National Guideline for Pelvic Inflammatory Disease
  • BASHH: Pelvic inflammatory disease patient information
  • NHS: Pelvic inflammatory disease
  • NHS Forth Valley: Tubo-ovarian abscess antimicrobial guidance

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom